The Ubiquitin-Conjugating Enzyme E2-EPF Is Overexpressed in Primary Breast Cancer and Modulates Sensitivity to Topoisomerase II Inhibition
Open Access
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Proliferation: the Most Prominent Predictor of Clinical Outcome in Breast CancerCell Cycle, 2006
- E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasisNature Medicine, 2006
- Common markers of proliferationNature Reviews Cancer, 2006
- The Novel Poly(ADP-Ribose) Polymerase Inhibitor, AG14361, Sensitizes Cells to Topoisomerase I Poisons by Increasing the Persistence of DNA Strand BreaksClinical Cancer Research, 2005
- Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cellsActa Oncologica, 2005
- Java Treeview—extensible visualization of microarray dataBioinformatics, 2004
- The cytoplasmic trafficking of DNA topoisomerase IIα correlates with etoposide resistance in human myeloma cellsExperimental Cell Research, 2004
- Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An UpdateBreast Cancer Research and Treatment, 2004
- 26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable ComplexesJournal of Biological Chemistry, 2001
- Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIα expression☆Biochemical Pharmacology, 2001